DHI vs OKUR · P/E 9.6, rev $34.25B vs P/E 72, rev $2.0M
DR Horton Inc (DHI) versus OnKure Therapeutics, Inc. (OKUR) — a side-by-side from cached financials, not a winner call.
DR Horton Inc (DHI) is a residential construction company listed on US.
OnKure Therapeutics, Inc. (OKUR) is a biotechnology company listed on US.
Latest reported DHI revenue for 2025-09-30 was $34.25B. Net income was $3.62B. DHI currently screens at market cap $39.10B and trailing P/E 9.6.
Latest reported OKUR revenue for 2026-06-30 was $2.0M. Net income was -$30.5M. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
DHI currently screens at market cap $39.10B and trailing P/E 9.6. OKUR currently screens at market cap $76.6M and trailing P/E 71.8.
Not investment advice. Open the DHI and OKUR stock pages for the full models.
Not investment advice.